These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28471096)

  • 21. The Emergence of New Psychoactive Substance (NPS) Benzodiazepines. A Survey of their Prevalence in Opioid Substitution Patients using LC-MS.
    Mc Namara S; Stokes S; Nolan J
    Ir Med J; 2019 Aug; 112(7):970. PubMed ID: 31642644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods.
    Laing MK; Ti L; Marmel A; Tobias S; Shapiro AM; Laing R; Lysyshyn M; Socías ME
    Int J Drug Policy; 2021 Jul; 93():103169. PubMed ID: 33627302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Next generation of novel psychoactive substances on the horizon - A complex problem to face.
    Zawilska JB; Andrzejczak D
    Drug Alcohol Depend; 2015 Dec; 157():1-17. PubMed ID: 26482089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel psychoactive substances: the pharmacology of stimulants and hallucinogens.
    Schifano F; Papanti GD; Orsolini L; Corkery JM
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):943-54. PubMed ID: 26985969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of use and toxicity of new para-halogenated substituted cathinones: 4-CMC (clephedrone), 4-CEC (4-chloroethcatinone) and 4-BMC (brephedrone).
    Grifell M; Ventura M; Carbón X; Quintana P; Galindo L; Palma Á; Fornis I; Gil C; Farre M; Torrens M
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28657185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project.
    Brunt TM; Nagy C; Bücheli A; Martins D; Ugarte M; Beduwe C; Ventura Vilamala M
    Drug Test Anal; 2017 Feb; 9(2):188-198. PubMed ID: 26888408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mental illness and psychotropic drug use among prescription drug overdose deaths: a medical examiner chart review.
    Toblin RL; Paulozzi LJ; Logan JE; Hall AJ; Kaplan JA
    J Clin Psychiatry; 2010 Apr; 71(4):491-6. PubMed ID: 20409446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports.
    Orsolini L; Corkery JM; Chiappini S; Guirguis A; Vento A; De Berardis D; Papanti D; Schifano F
    Curr Neuropharmacol; 2020; 18(9):809-837. PubMed ID: 31933443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography-tandem mass spectrometry.
    Adamowicz P; Tokarczyk B
    Drug Test Anal; 2016 Jul; 8(7):652-67. PubMed ID: 25976069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Psychoactive substances in biological samples--toxicological laboratory data].
    Gomółka E; Wilimowska J; Piekoszewski W; Groszek B
    Przegl Lek; 2004; 61(4):323-7. PubMed ID: 15521594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic analytical characterization of new psychoactive substances: A case study.
    Lobo Vicente J; Chassaigne H; Holland MV; Reniero F; Kolář K; Tirendi S; Vandecasteele I; Vinckier I; Guillou C
    Forensic Sci Int; 2016 Aug; 265():107-15. PubMed ID: 26874735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The rise of new psychoactive substance use in Australia.
    Burns L; Roxburgh A; Matthews A; Bruno R; Lenton S; Van Buskirk J
    Drug Test Anal; 2014; 6(7-8):846-9. PubMed ID: 24599890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS, 'legal highs') in New Zealand.
    Rychert M; Wilkins C
    Int J Drug Policy; 2016 Nov; 37():90-97. PubMed ID: 27639994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of pregnancy on psychoactive substance use among women with substance use disorders recruited in addiction specialized care centers in France.
    Pochard L; Dupouy J; Frauger E; Giocanti A; Micallef J; Lapeyre-Mestre M;
    Fundam Clin Pharmacol; 2018 Apr; 32(2):188-197. PubMed ID: 29337399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychoactive drug abuse in older adults.
    Simoni-Wastila L; Yang HK
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):380-94. PubMed ID: 17296542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Structure of psychoactive substances determined in medical toxicology laboratory].
    Gomółka E; Łabuz K; Gawlikowski T
    Przegl Lek; 2010; 67(8):580-2. PubMed ID: 21387781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New psychoactive substances require a paradigm shift in drug testing in Denmark].
    Breindahl T; Hindersson P; Leutscher PD; Kimergård A
    Ugeskr Laeger; 2018 Mar; 180(11):. PubMed ID: 29530235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing diversion of prescribed benzodiazepines and Z-drugs to new psychoactive substances.
    Del Rio A; Graziano S; Tittarelli R; Umani-Ronchi F
    Clin Ter; 2021 Mar; 172(2):116-118. PubMed ID: 33763670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging Agents of Substance Use/Misuse.
    Michienzi AE; Borek HA
    Emerg Med Clin North Am; 2022 May; 40(2):265-281. PubMed ID: 35461623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.